WordNet

a silvery soft waxy metallic element of the alkali metal group; occurs abundantly in natural compounds (especially in salt water); burns with a yellow flame and reacts violently in water; occurs in sea water and in the mineral halite (rock salt) (同)Na, atomic number 11

PrepTutorEJDIC

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/11/08 00:55:12」(JST)

Cefpiramide is a third-generation cephalosporin antibiotic.

Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M (2000). "In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China". J Infect Chemother 6 (2): 81–85. doi:10.1007/PL00012156. PMID 11810540.
Iakovlev V, Vishnevskiĭ V, Khlebnikov E, Khadin I, Plavlova M, Elagina L, Izotova G (1995). "[Cefpiramide (Tamicin) in the treatment of purulent complications of abdominal surgery]". Antibiot Khimioter 40 (9): 30–4. PMID 8651827.
Sampi K, Hattori M (1992). "[Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study]". Gan to Kagaku Ryoho 19 (9): 1315–20. PMID 1503486.

This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis.

Jeong N1, Kim JY, Park SC, Lee JK, Gopal R, Yoo S, Son BK, Hahm JS, Park Y, Hahm KS.
Biochemical and biophysical research communications.Biochem Biophys Res Commun.2010 Sep 3;399(4):581-6. doi: 10.1016/j.bbrc.2010.07.118. Epub 2010 Aug 2.
Pseudomonas aeruginosa has eventually developed resistance against flomoxef sodium, isepamicin and cefpiramide. Therefore, in this study, the antibacterial activity and synergistic effects of the amphipathic-derived P5-18mer antimicrobial peptide were tested against pathogens associated with choleli
PMID 20682287

The efficacy of postoperative prophylactic antibiotics in orthognathic surgery: a prospective study in Le Fort I osteotomy and bilateral intraoral vertical ramus osteotomy.

Kang SH1, Yoo JH, Yi CK.
Yonsei medical journal.Yonsei Med J.2009 Feb 28;50(1):55-9. doi: 10.3349/ymj.2009.50.1.55. Epub 2009 Feb 24.
PURPOSE: This study examined the efficacy of the postoperative prophylactic antibiotics used in orthognathic surgery. The prevalence of surgical site infections (SSIs) was determined according to the use of postoperative prophylactic antibiotics.PATIENTS AND METHODS: Fifty-six patients were divided
PMID 19259349

小島直彦,熊本いずみ,舛本俊一,恩地森一
アレルギー 43(3), 511-514, 1994-03-30
セファロスポリン系抗生剤による薬物アレルギー性肝炎の1例を経験し, リンパ球幼若化試験により, セファロスポリンのうちN-methyltetrazolethiol基が原因であることが示唆された症例を経験したので報告した.
NAID 110002422465

Electrokinetic Chromatography for Drug Analysis. Separation and Determination of Cefpiramide in Human Plasma

中川照眞,小田吉哉,澁川明正,福田桐子,田中久
Chemical & pharmaceutical bulletin 37(3), 707-711, 1989-03-25
… Electrokinetic chromatography using a fused silica capillary and sodium dodecyl sulfate (SDS) solution has been applied to the separation and determination of cefpiramide (CPM) in human plasma with the use of antipyrine (AP) as an internal standard. …
NAID 110003627590

リンク元	「セフピラミド」「セフピラミドナトリウム」
関連記事	「cefpiramide」

Cefpiramide
Systematic (IUPAC) name
	(6R)-7-{[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-; 4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino}-; 3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-; 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Intravenous, intramuscular
Pharmacokinetic data
Protein binding	93% to 99.3%
Biological half-life	4.44 hours
Excretion	Renal and fecal
Identifiers
CAS Registry Number	70797-11-4
ATC code	J01DD11
PubChem	CID: 636405
DrugBank	DB00430
ChemSpider	552192
UNII	P936YA152N
KEGG	D03428
ChEBI	CHEBI:59213
ChEMBL	CHEMBL1201204
Chemical data
Formula	C25H24N8O7S2
Molecular mass	612.64 g/mol
	SMILES O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)[C@@H](c3ccc(O)cc3)NC(=O)C\4=C\N\C(=C/C/4=O)C)CSc5nnnn5C)C(=O)O ;
	InChI InChI=1S/C25H24N8O7S2/c1-11-7-16(35)15(8-26-11)20(36)27-17(12-3-5-14(34)6-4-12)21(37)28-18-22(38)33-19(24(39)40)13(9-41-23(18)33)10-42-25-29-30-31-32(25)2/h3-8,17-18,23,34H,9-10H2,1-2H3,(H,26,35)(H,27,36)(H,28,37)(H,39,40)/t17-,18-,23-/m1/s1 ; Key:PWAUCHMQEXVFJR-PMAPCBKXSA-N ;
(what is this?) (verify)